Publications by authors named "Daniel Blakemore"

5Publications

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations.

Life Sci Alliance 2019 04 15;2(2). Epub 2019 Mar 15.

Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26508/lsa.201800207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421631PMC
April 2019

mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome.

Oncotarget 2018 Dec 25;9(101):37460-37461. Epub 2018 Dec 25.

Paloma García: Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331017PMC
December 2018

MYBL2 Supports DNA Double Strand Break Repair in Hematopoietic Stem Cells.

Cancer Res 2018 10 6;78(20):5767-5779. Epub 2018 Aug 6.

Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-18-0273DOI Listing
October 2018

Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature.

Sci Rep 2017 09 11;7(1):11148. Epub 2017 Sep 11.

Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-11718-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593973PMC
September 2017